Published Date: 04 Aug 2023
USA: Scientists at the Massachusetts Institute of Technology (MIT) have developed an ultrasound tool that might help people find tumors.
Read Full NewsA new phase 2 study presented at AES 2025 showed that stiripentol may reduce seizure burden in patients with Lennox-Gastaut syndrome.
Sharon Hesterlee, PhD, President and CEO of the Muscular Dystrophy Association, discussed the 2026 MDA Conference, the significance of its keynote speaker, and the evolving therapeutic landscape in neuromuscular medicine.
A new study presented at AES 2025 examined factors linked to declining surgery for pediatric drug-resistant epilepsy and highlighted variability in candidate selection across centers.
The positive interim findings research represents the first clinical data for ETX101, an investigational cell-type-selective gene therapy, and the first potential one-time disease-modifying treatment for Dravet syndrome.
Lingdolinurad Demonstrates Dose-Dependent Serum Uric Acid Reductions
House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma
AI in Dermatology: Discussing Downsides to the Adoption of Artificial Intelligence
1.
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
2.
O. A. J. Simpson passes away from cancer.
3.
Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.
4.
An ultrasound breast patch with conformability might help with early breast cancer detection.
5.
Weight loss trial reports success for breast cancer patients at one year mark
1.
Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment
2.
Understanding Fibrosarcoma: What You Need to Know
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide
5.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation